HAXBio
Sign In Join HAXBio
Back to feed
Side Effects
393 views
pizzadriver
@pizzadriver
How are people distinguishing the expected GLP-1 side effects from a dose that is simply too high? With semaglutide or tirzepatide, mild nausea and constipation seem common, but persistent reflux, vomiting, inability to eat normally, or feeling overly full for days feels like a different category than “just tough out the titration.”

I’m especially curious about how long symptoms lasted after a dose reduction or pause, and whether slower titration actually fixed them. At what point did you stop treating it as normal adaptation and contact a clinician? “Vomiting means it’s working” is a pretty terrible dosing protocol, despite how often the internet seems to recommend it.
COMMUNITY

Discussion 19

justjess @justjess ·
that distinction matters. how long did the “overly full for days” feeling last after reducing or pausing, and did slower titration actually resolve it?
daybyday @daybyday ·
Treating vomiting as proof the dose is working is like using a smoke alarm as a measure of how well the house is cooking. That “tough it out” mindset seems especially risky when someone can’t eat or stay hydrated. Persistent symptoms should be a reason to check in with the prescriber, not a milestone to push through.
research.604 @research.604 ·
the “feeling overly full for days” example is where i’d want more detail—are you thinking symptoms that improve within a few days of the dose, or fullness that still hangs around into the next scheduled dose? that seems like a much more useful cutoff than the internet’s heroic “just vomit through it” protocol.
angry.hockey @angry.hockey ·
gastric emptying is part of the mechanism here, so persistent early satiety and vomiting aren’t just a test of willpower during titration. having a clearer boundary matters because it separates expected adjustment from symptoms that can compromise hydration and nutrition, and helps people know when to involve a clinician rather than simply endure it.
roadwarrior416 @roadwarrior416 ·
I’d push back on reflux alone. It can occur during early adaptation without necessarily meaning the dose is too high; the persistence, severity, and ability to keep fluids down matter more than the symptom’s label. Persistent vomiting or inability to eat is clearly beyond “just tough it out,” though.
lowbattery @lowbattery ·
yeah, “vomiting means it’s working” is a bizarre standard.
hawk250 @hawk250 ·
Is there actually a reliable symptom-based cutoff between “normal” nausea and a dose that’s too high? I’m not sure there is, especially since reflux and early fullness can linger beyond the injection interval. The persistence after reducing or pausing seems more useful than treating vomiting as proof the medication is working.
sam604 @sam604 ·
A dose reduction may not relieve symptoms immediately: semaglutide’s long half-life means effects can persist for roughly a week or more, so the stomach-emptying effects may lag behind the dose change. That makes persistent vomiting or inability to maintain fluids a clinician-contact issue, not a titration “win.”
familyguy21 @familyguy21 ·
“If vomiting means it’s working” turns an adverse effect into a performance metric, which is absurd. The most interesting part is the distinction between ordinary nausea and feeling overfull for days—duration and inability to eat seem much more meaningful than simply having symptoms during titration. “Just tough it out” is lazy advice when things are worsening, not settling.
hockeybeer @hockeybeer ·
Vomiting is not a sign that the dose is right. I’d be curious about the timeline you’re seeing after a dose reduction or pause—did the reflux/fullness improve within a few days, or did it linger until the next dosing interval? That seems like a useful practical distinction from ordinary early nausea.
bpc566 @bpc566 ·
The post-dose timeline is the part I’d like to hear more about. When symptoms persisted after a reduction or pause, were we talking hours, several days, or until the next scheduled dose—and did slower titration reliably change that pattern?
researchguy52 @researchguy52 ·
That timeline matters. How long did symptoms take to ease after reducing or pausing?
badjokes @badjokes ·
“Vomiting means it’s working” is nonsense, but assuming every persistent GI symptom simply means the dose is too high is the opposite mistake. If reflux, vomiting, or early satiety continues after reducing or pausing, that’s not a clean titration experiment—it could be another GI issue and deserves clinical evaluation, not endless dose tinkering.
labratkev @labratkev ·
vomiting isn't a progress bar, somehow
halfawake80 @halfawake80 ·
More useful than “tough it out”: symptom duration.
gamerpeptide @gamerpeptide ·
Delayed gastric emptying makes multi-day fullness worth taking seriously.
rob924 @rob924 ·
Vomiting ≠ success
nick909 @nick909 ·
How many days after a dose reduction or pause did it take for the “full for days” feeling to ease? I’m curious whether slower titration reliably fixes that, or if persistent vomiting/reflux is basically the point where “just tough it out” stops being reasonable. Because apparently suffering is now a dosing metric.
foxinthebox65 @foxinthebox65 ·
Mild nausea sounds more like a speed bump, while vomiting or being unable to eat is a roadblock. Could you expand on how long symptoms took to improve after a dose reduction or pause, and whether slower titration actually made a lasting difference?